A 48-year-old man underwent elective percutaneous coronary intervention of a mid-left anterior descending (LAD) artery bifurcation lesion. A dedicated bifurcation self-expanding biolimuseluting stent (3.0 Â 14 mm AXXESS, Biosensors International, Morges, Switzerland) was implanted in the mid-LAD abutting the carina of the LAD and first diagonal (D1) bifurcation. Three balloonexpandable biolimus-eluting stents (Biomatrix, Biosensors) were placed proximal to the previous stent and in the distal main branch and the D1 side branch overlapping the AXXESS stent in a Y-configuration (Fig. 1A) . High-pressure postdilation of the proximal main vessel was performed with a 3.0-mm noncompliant balloon.
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The patient underwent a 12-month follow-up coronary angiogram that showed a large coronary aneurysm in the mid-LAD (Fig. 1B) . Optical coherence tomography showed significant positive remodeling in the segment covered by the self-expanding stent that peeled away from the overlapping balloonexpandable stents (Fig. 2, Online Video 1 ). There was evidence of endothelialization of both the inner balloonexpandable stent and the outer peeled-away self-expanding stent (Fig. 2C) . As a result, there was late acquired incomplete stent apposition within the overlapping stented segment.
Coronary artery aneurysm after drug-eluting stent implantation is rare. A possible cause is localized hypersensitivity reaction to the antirestenotic drug, polymer, or the stent material (1) . The rationale of a dedicated selfexpanding bifurcation stent is to provide an anatomicallytailored treatment of the bifurcation with optimal stent apposition and maximum drug coverage (2,3). Four biolimus-eluting stents with the same biodegradable polymer were implanted in our patient, but aneurysmal change only occurred in the segment covered by the selfexpanding stent. It is unknown whether the self-expanding force contributed to the positive remodeling and aneurysmal changes. Our case demonstrated that caution should be taken when overlapping self-expanding and balloonexpandable stents. Although stent apposition may be maintained by the self-expanding nature, late acquired stent malapposition may occur in the overlapping segment.
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